These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25015537)

  • 41. Optimistic Bias and Consumer Prescription Drug Decisions: Influences of Direct to Consumer Advertising and Perceived Susceptibility.
    Ju I; Park T; Ohs J
    Health Commun; 2022 Nov; 37(13):1694-1703. PubMed ID: 33899598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid.
    Law MR; Soumerai SB; Adams AS; Majumdar SR
    Arch Intern Med; 2009 Nov; 169(21):1969-74. PubMed ID: 19933958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct-to-consumer drug marketing: public service or disservice?
    Berger JT; Kark P; Rosner F; Packer S; Bennett AJ
    Mt Sinai J Med; 2001 May; 68(3):197-202. PubMed ID: 11373692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Information shocks and pharmaceutical firms' marketing efforts: Evidence from the Chantix black box warning removal.
    Lawler EC; Skira MM
    J Health Econ; 2022 Jan; 81():102557. PubMed ID: 34896791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Social representation of persons with disabilities in marketing and advertising practice].
    Nadutkina IE; Elnikova GA; Korshunov AM; Kotovskaya MG
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2023 Aug; 31(Special Issue 1):752-755. PubMed ID: 37742245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.
    Mintzes B; Morgan S; Wright JM
    PLoS One; 2009 May; 4(5):e5699. PubMed ID: 19479084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.
    Khalil Zadeh N; Robertson K; Green JA
    BMJ Open; 2017 Dec; 7(12):e017865. PubMed ID: 29217723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
    Faerber AE; Kreling DH
    J Gen Intern Med; 2014 Jan; 29(1):110-8. PubMed ID: 24030427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Better the devil you know than the doctor you don't: is advertising drugs to doctors more harmful than advertising to patients?
    Vaithianathan R
    J Health Serv Res Policy; 2006 Oct; 11(4):235-9. PubMed ID: 17018198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct-to-consumer advertising affects provider / patient relationship.
    Contracept Technol Update; 1998 Dec; 19(12):153-5. PubMed ID: 12321805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Designing pharmacy services based on grocery store patron preferences.
    Lindstrom NS; Casper KA; Green TR; Pedersen CA
    J Am Pharm Assoc (2003); 2007; 47(5):605-12. PubMed ID: 17848350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Marketing drugs, marketing health care relationships: a content analysis of visual cues in direct-to-consumer prescription drug advertising.
    Welch Cline RJ; Young HN
    Health Commun; 2004; 16(2):131-57. PubMed ID: 15090282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Communication Strategies in Direct-to-Consumer Prescription Drug Advertising (DTCA): Application of the Six Segment Message Strategy Wheel.
    Ju I; Park JS
    J Health Commun; 2015; 20(5):546-54. PubMed ID: 25794304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bright ideas to market your department.
    Kelley P
    Biomed Instrum Technol; 2003; 37(4):249-53. PubMed ID: 12923975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications.
    Mackey TK; Cuomo RE; Liang BA
    BMC Health Serv Res; 2015 Jun; 15():236. PubMed ID: 26084705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Why the "sea of same"? A qualitative look at DTCA within the larger context of healthcare marketing.
    Macias W
    Health Mark Q; 2020; 37(2):155-175. PubMed ID: 32319874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws.
    Nathenson R; Richards MR
    Int J Health Econ Manag; 2018 Sep; 18(3):321-336. PubMed ID: 29380108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Father and sons: Feller family members in the context of the beginnings of advertising in Croatia].
    Fatović-Ferenčić S; Ferber Bogdan J
    Acta Med Hist Adriat; 2018 Jul; 16(1):49-74. PubMed ID: 30198272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Illicit online marketing of lorcaserin before DEA scheduling.
    Liang BA; Mackey TK; Archer-Hayes AN; Shinn LM
    Obesity (Silver Spring); 2013 May; 21(5):861-4. PubMed ID: 23512816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.